Bayer and Salus Optima Partner on AI-Enabled Healthy Aging Journey
Salus Optima, a leading provider in AI-enabled digital health and wellness solutions, and the Consumer Health division of Bayer have launched a strategic partnership to empower people on their healthy aging journey. The partnership elevates the shared aspiration of both companies to transform self-care by offering precision health solutions to enable consumers to better understand and make informed decisions about their own personal health and lifestyle choices. 
Ebenbuild, a company developing personalized, AI-driven virtual lungs to support clinical decisions and digital clinical trials, announced its participation in the research project Personalized Lung Twins for the Treatment of Acute Respiratory Distress Syndrome (UBIC) in collaboration with the University Hospital Schleswig-Holstein, Augsburg University Hospital, University Hospital Carl Gustav Carus Dresden, University Hospital RWTH Aachen and University Medical Center Mannheim. 
The European start-up HealthSage AI announces the launch of its Open Source Generative AI Platform fully dedicated to healthcare: a trusted and transparent foundation for the development of AI applications for healthcare.
The NHS exists to serve patients. But more could be done to make their experience a key focus when it comes to technology adoption, senior NHS delegates told a recent roundtable. SPARK TSL reports.